The time-dependent expression of fibronectin, MRP8, MRP14 and defensin in surgically treated human skin wounds

Forensic Science International

Volumn 131, Issue 2-3, 2003, Pages 156-161

  Fieguth, A ^a   Feldbrugge H ^a   Gerich, T ^a   Kleemann, W J ^b   Troger H D ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Defensin; Fibronectin; MRP14; MRP8; Wound age

Indexed keywords

CALGRANULIN; DEFENSIN; FIBRONECTIN;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY;

EID: 0037469303     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(02)00428-0     Document Type: Article

References (39)

1. P. Betz, Neue Methoden zur histologischen Altersbestimmung menschlicher Hautwunden (Arbeitsmethoden der Medizinischen und Naturwissenschaftlichen Kriminalistik), vol. 20, Schmidt-Römhild, Lübeck, 1996.
2. Oehmichen M., Schmidt V., Stuka K. Freisetzung von Proteinase-Inhibitoren als vitale Reaktion im frühen post-traumatischen Intervall. Z. Rechtsmed. 102:1989;461-472.
3. Betz P., Nerlich A., Wilske J., Tübel J., Wiest I., Penning R., Eisenmenger W. The immunohistological localization of alpha-1-antichymotrypsin and fibronectin and its meaning for the determination of the vitality of human skin wounds. Int. J. Leg. Med. 105:1993;223-227.
4. Fieguth A., Kleemann W.J., Tröger H.D. Immunohistochemical examination of skin wounds with antibodies against alpha-1-antichymotrypsin, alpha-2-macroglobulin and lysozyme. Int. J. Leg. Med. 10:1994;29-33.
5. Dressler J., Bachmann L., Kasper M., Hauck J.G., Müller E. Time dependence of the expression of ICAM-1 (CD 54) in human skin wounds. Int. J. Leg. Med. 110:1997;299-304.
6. Dressler J., Bachmann L., Koch R., Müller E. Enhanced expression of selectins in human skin wounds. Int. J. Leg. Med. 112:1998;39-44.
7. Dressler J., Bachmann L., Koch R., Müller E. Estimation of wound age and VCAM-1 in human skin. Int. J. Leg. Med. 112:1999;159-162.
8. Betz P., Nerlich A., Wilske J., Tübel J., Wiest I., Penning R., Eisenmenger W. Immunohistochemical localization of fibronectin as a tool for age determination of human skin wounds. Int. J. Leg. Med. 105:1992;21-26.
9. B. Madea, W. Grellner, Vitality and supravitality in forensic medicine, in: M. Oehmichen, H. Kirchner (Eds.), The Wound Healing Process - Forensic Pathological Aspects (Research in Legal Medicine), vol. 13, Schmidt-Römhild, Lübeck, 1996, pp. 259-282.
10. Grellner W., Dimmeler S., Madea B. Immunohistochemical detection of fibronectin in post-mortem incised wounds of porcine skin. Forensic Sci. Int. 97:1998;109-116.
11. Betz P., Nerlich A., Wilske J., Tübel J., Penning R., Eisenmenger W. The immunohistochemical analysis of fibronectin, collagen type III, laminin, and cytokeratin 5 in putrified skin. Forensic Sci. Int. 61:1993;35-42.
12. Fieguth A., Kleemann W.J., von Wasielewski R., Werner M., Tröger H.D. Influence of post-mortem changes on immunohistochemical reactions in skin. Int. J. Leg. Med. 110:1997;18-21.
13. Ortmann C., Pfeiffer H., Brinkmann B. Demonstration of myocardial necrosis in the presence of advanced putrefaction. Int. J. Leg. Med. 114:2000;50-55.
14. Stenman S., Vaheri A. Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J. Exp. Med. 147:1978;1054-1064.
15. Ruoslathi E., Vaheri A. Novel human serum protein from fibroblast plasma membrane. Nature. 248:1974;789-791.
16. Jaffee E.A., Mosher D.F. Synthesis of fibronectin by cultured human endothelial cells. J. Exp. Med. 147:1978;1779-1791.
17. Yamada K.M., Olden K. Fibronectins - adhesive glycoproteins of cell surface and blood. Nature. 275:1978;179-184.
18. Alitalo K., Hovi T., Vaheri A. Fibronectin is produced by human macrophages. J. Exp. Med. 147:1980;1779-1791.
19. Vaheri A., Ruoslathi E., Westermark B., Pontén J.A. Common cell type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J. Exp. Med. 143:1976;64-72.
20. Postlethwaite A.E., Keshi-Oja J., Balian G., Kang A.H. Induction of fibroblast chemotaxis by fibronectin. J. Exp. Med. 153:1981;494-499.
21. Molnar J., Gelder F.B., Lai M., Siefring G.E., Credo R.B., Lorand L. Purification of opsonically active human and rat cold insoluble globulin (plasma fibronectin). Biochemistry. 18:1979;3909-3915.
22. Grinnel F. The fibroblast receptor for cell-substratum adhesions: studies on the interaction of baby hamster kidney with latex beads coated by cold insoluble globulin (plasma fibronectin). J. Cell. Biol. 86:1980;104-112.
23. Clark R.A.F., DellaPelle P., Manseau E., Lanigan J.M., Dvorak H.F., Colvin R.B. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary in-growth during wound healing. J. Invest. Dermatol. 79:1982;269-276.
24. Niewiarowski S., Regoezi E., Mustard J.F. Adhesion of fibroblasts to polymerizing fibrin and retraction of fibrin induced by fibroblasts. Proc. Soc. Exp. Biol. Med. 140:1972;199-204.
25. R. Amberg, Time dependent cytokine expression in cutaneous wound-repair, in: M. Oehmichen, H. Kirchner (Eds.), The Wound Healing Process - Forensic Pathological Aspects (Research in Legal Medicine), vol. 13, Schmidt-Römhild, Lübeck, 1996, pp. 107-121.
26. Odnik K., Cerletti N., Brüggen J., Clerc R.G., Tarcsay L., Zwadlo G., Gerhards G., Schlegel R., Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 330:1987;80-82.
27. +)-binding proteins of neutrophils and monocytes. J. Leuk. Biol. 53:1993;197-204.
28. Kagan B.L., Ganz T., Lehrer R.I. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology. 87:1993;131-149.
29. Ganz T., Lehrer R.I. Defensins. Curr. Opin. Immunol. 6:1994;584-589.
30. Grinnel F., Billingham R.E., Burgess L. Distribution of fibronectin during wound healing in vivo. J. Invest. Dermatol. 76:1981;181-189.
31. Fechner G., Bajanowski T., Brinkmann B. Immunohistochemical alterations after muscle trauma. Int. J. Leg. Med. 105:1993;203-207.
32. G. Fechner, Immunhistochemische Untersuchungen bei Muskeltraumen, in: H. Bratzke, A. Schröter (Eds.), Immunhistochemie in der Rechtsmedizin, Deutsche Hochschulschriften 1068, Hänsel-Hohenhausen, Egelsbach, Frankfurt, Washington, DC, 1995, pp. 22-36.
33. Casscells W., Kimura H., Sanchez J., Yu Z., Ferrans V. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am. J. Path. 137:1990;801-810.
34. Hu B., Chen Y., Zhu J. Immunohistochemical study of fibronectin for post-mortem diagnosis of early myocardial infarction. Forensic Sci. Int. 78:1996;209-217.
35. Ortmann C., Pfeiffer H., Brinkmann B. A comparative study on the immunohistochemical detection of early myocardial damage. Int. J. Leg. Med. 113:2000b;215-220.
36. Ortiz-Rey J.A., Suàrez-Peñaranda J.M., Da Silva E.A., Muñoz J.I., San Miguel-Fraile P., De la Fuente-Buceta A., Concheiro-Carro L. Immunohistochemical detection of fibronectin and tenascin in incised human skin injuries. Forensic Sci. Int. 126:2002;118-122.
37. K. Püschel, W. J. Schulz-Schaeffer, W. Brück, Time dependent morphological alteration of injection marks, in: M. Oehmichen, H. Kirchner (Eds.), The Wound Healing Process - Forensic Pathological Aspects (Research in Legal Medicine), vol. 13, Schmidt-Römhild, Lübeck, 1996, pp. 293-307.
38. Schulz-Schaeffer W.J., Brück W., Püschel K. Macrophage subtyping in the determination of age of injection marks. Int. J. Leg. Med. 109:1996;29-33.
39. W. Janssen, Forensic Histopathology, Springer, Berlin, 1984.